A randomised control trial of parent and child training programmes (versus wait list control) for children with ADHD-type behaviours: a pilot stud. Child Care Pract. 2019; 25(4):419438. [STEP 2] 3. Wolraich ML, Hagan JF Jr, Allan C, et al; Subcommittee on children and adolescents with attention deficit/hyperactive disorder. Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents.
In outpatients with active cancer on chemotherapy, treatment with low-molecular-weight heparin (LMWH) reduces the risk of symptomatic venous thromboembolism (VTE) compared with no thromboprophylaxis (number needed to treat 37), whereas warfarin and the direct oral anticoagulants apixaban and rivaroxaban do not significantly reduce VTE risk compared with placebo (SOR: A, systematic review of randomized controlled trials [RCTs]). However, LMWH (but not warfarin, apixaban, or rivaroxaban) increases the risk of major bleeding (number needed to harm 144) when compared with placebo or no thromboprophylaxis (SOR: A, systematic review of RCTs). Oncology guidelines recommend offering rivaroxaban, apixaban, or LMWH to cancer patients on chemotherapy who are at intermediate to high risk of VTE and have a low risk of bleeding, after shared decision making. Guidelines recommend against routine use of anticoagulation in all ambulatory patients with cancer on systemic therapy (SOR: C, expert opinion).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.